Respiratory Monitoring: Is Your SpO₂ Reading Dangerous? [2026]

Introduction

Respiratory monitoring begins with one number.

That number is your SpO₂ — your blood oxygen saturation. In healthy adults at sea level, it reads 95–100%. If it drops below 90%, that is a medical emergency.

If you are reading this because a device just gave you a reading and you do not know what to do with it, you are in the right place. This guide, reviewed by Dr. Rishav Das, M.B.B.S., answers the questions patients with COPD, asthma, and sleep apnea ask most often:

• Is my SpO₂ reading actually dangerous?
• Is my device accurate enough to trust?
• What is my target range if I have COPD?
• When do I call emergency services?

We cover normal SpO₂ ranges by condition, what affects reading accuracy (including what the FDA found about skin tone), how to interpret your COPD-specific target range under GOLD 2024 guidelines, and the step-by-step process for taking a reliable reading at home.

⚠️ If your current reading is below 90% and you are experiencing difficulty breathing, do not continue reading — call emergency services now.

Reviewed by Dr. Rishav Das, M.B.B.S. (MCI: PR/7466/2024 | ORCID: 0009-0007-2692-4542)

Who This Page Is For

This guide is written for:

• Adults managing COPD, asthma, sleep apnea, or recovering from a respiratory illness
• Caregivers supporting a family member with a chronic respiratory condition
• Anyone who wants to understand what their pulse oximeter readings actually mean If you have a specific condition, your doctor may have set a personal SpO₂ target that differs from the general ranges shown here. Always follow your individualized care plan.

Educational content only. This page supplements — and does not replace — professional medical care. Always consult a licensed healthcare provider for diagnosis, treatment, or changes to your care plan. See our About page for full medical oversight standards.

SpO₂ Normal Range by Condition and Age

What is a normal oxygen level at home? For most healthy adults at rest and at sea level, a reading between 95% and 100% is normal. See the condition-specific ranges in the table below.

What Causes Low Oxygen Saturation?

If You Have Darker Skin: What You Need to Know About Pulse Oximeter Accuracy

The FDA has confirmed that standard pulse oximeters may read 2–4% higher than your actual oxygen level if you have darker skin. This is due to how these devices were calibrated — using data primarily from lighter-skinned individuals.

What this means for you:

  • Your displayed SpO₂ may appear normal even when your true level is lower.

  • Do not rely solely on a single SpO₂ reading to assess your status.

  • Ask your healthcare provider about periodic verification through arterial blood gas (ABG) testing to establish your accurate personal baseline.

  • When in doubt, act on symptoms — not just the number on the device. The FDA is actively reviewing device standards. Until updated devices are widely certified, clinical correlation is especially important for this group.

SpO₂ vs. SaO₂: What the Difference Means for Your Device

SpO₂ (peripheral oxygen saturation) is a non-invasive estimate of arterial oxygen saturation (SaO₂) measured using light sensor technology (PPG — photoplethysmography).

A pulse oximeter shines a small light through your fingertip to detect how much oxygen your red blood cells are carrying. A pulse oximeter emits light at two wavelengths (typically 660 nm red and 940 nm infrared) through a capillary bed; oxygenated and deoxygenated hemoglobin absorb light differently, allowing a ratio to be calculated.[6]

Clinical note: SpO₂ is an estimate, not a direct measurement of blood oxygen. Invasive arterial blood gas (ABG) analysis provides SaO₂ and PaO₂ with higher precision. In clinical settings, SpO₂ is used for trending and screening; ABG is used for definitive assessment.

Do I Need a Pulse Oximeter at Home?

For most healthy adults without a chronic condition, a pulse oximeter is optional. For the groups below, the answer is a clear yes.

For under $30–$35, an FDA-cleared finger clip oximeter gives you reliable daily readings. See our top picks →

How PPG (Photoplethysmography) Technology Measures Blood Oxygen

• SpO₂ percentage is computed from empirical calibration curves derived from healthy volunteer studies. This calibration data influences accuracy at low saturation levels.
• A light-emitting diode (LED) shines red (660 nm) and infrared (940 nm) light through the tissue (typically a fingertip or earlobe).
• A photodetector on the opposite side measures light absorption. Oxygenated hemoglobin absorbs more infrared; deoxygenated hemoglobin absorbs more red light.
• The device calculates the ratio of pulsatile (arterial) to non-pulsatile (venous and tissue) absorption — isolating the arterial signal.

Finger Clip vs. Wearable vs. Ring Oximeter: Accuracy Compared

Quick Answer: FDA-cleared finger clip pulse oximeters achieve SpO₂ accuracy of ±2%. Consumer smartwatches typically achieve ±3–4%. No consumer smartwatch SpO₂ function is FDA-cleared as a diagnostic medical device.

Both finger clip pulse oximeters and consumer smartwatches measure blood oxygen using photoplethysmography (PPG) — an optical method that shines light through tissue and detects how much is absorbed by oxygenated versus deoxygenated haemoglobin. The physics are the same. The accuracy is not.

Why finger clip devices are more accurate:

Finger clip oximeters press directly against the fingertip, where capillary density is high and the optical path is consistent. Consumer wrist wearables measure from a curved surface with variable contact pressure, higher motion artifact from wrist movement, and greater sensitivity to ambient light interference. Ring oximeters (Oura, Samsung Galaxy Ring) improve on wrist wearables by measuring from the finger, but current consumer models still fall short of FDA-cleared device accuracy standards.

What the accuracy difference means in practice:

The FDA’s position: No consumer smartwatch or ring device SpO₂ function has received FDA clearance as a diagnostic medical device. The FDA has explicitly stated this in guidance documents relating to pulse oximeter safety. A ±3–4% accuracy range means a true SpO₂ of 91% could read as 87–95% on a consumer device — a range that spans normal, concerning, and emergency thresholds simultaneously.

The appropriate use boundary: Consumer wearable SpO₂ readings are appropriate for tracking relative trends — whether your oxygen tends to drop during sleep, or how altitude affects your readings over time. They are not appropriate for making clinical decisions about supplemental oxygen titration, medication adjustments, or emergency care. If a wearable reading concerns you, confirm it with an FDA-cleared finger clip oximeter.

→  Ready to choose a device? See our Buying Guide — matched to your condition and budget. [link to Buying Guide page]

Consumer SpO₂ vs. Arterial Blood Gas (ABG): Clinical Limits

Quick Answer: Pulse oximetry (SpO₂) is a non-invasive estimate of oxygen saturation using optical sensors. Arterial blood gas (ABG) testing directly measures the partial pressure of oxygen dissolved in arterial blood (PaO₂), as well as CO₂, pH, and bicarbonate — parameters that pulse oximetry cannot detect at all.

SpO₂ and ABG measure related but fundamentally different things. SpO₂ tells you what percentage of haemoglobin molecules in your blood are carrying oxygen. ABG tells you how much oxygen is actually dissolved in your blood plasma (PaO₂), how efficiently CO₂ is being cleared, and whether your blood’s acid-base balance is normal.

Why this distinction matters clinically:

A patient with COPD and chronic CO₂ retention may have an SpO₂ reading of 91% — within their prescribed target range — while their ABG simultaneously reveals dangerously elevated CO₂ and a falling pH indicating respiratory acidosis. The pulse oximeter shows nothing unusual. The ABG reveals an emergency.

SpO₂ cannot detect:

• Hypercapnia (elevated CO₂) — a critical COPD complication
• Respiratory acidosis (falling blood pH due to CO₂ retention)
• Carboxyhemoglobin — carbon monoxide poisoning produces falsely normal or elevated SpO₂ readings
• Methaemoglobin — certain medications and exposures cause methaemoglobin, which reads as approximately 85% on pulse oximetry regardless of true saturation

When your provider orders an ABG instead of relying on SpO₂:

• During acute respiratory exacerbations requiring hospital management
• When CO₂ retention is suspected in COPD patients
• When there is a discrepancy between SpO₂ readings and clinical symptoms
• When carbon monoxide exposure is possible
• Before and after ventilator setting adjustments

For home monitoring: Your pulse oximeter is appropriate for tracking your SpO₂ trend at home between provider visits. It is not a substitute for ABG analysis in a clinical setting. If your provider orders an ABG, it means they need information that no consumer device can supply.

Quick Answer: In February 2021, the U.S. Food and Drug Administration issued a safety communication (FDA-2021-N-0010) confirming that standard pulse oximeters may systematically overestimate SpO₂ in individuals with darker skin pigmentation — a calibration bias that affects Fitzpatrick skin types IV–VI.

How the Fitzpatrick Scale Reveals Sensor Calibration Bias

The Fitzpatrick scale is a six-point classification of human skin pigmentation, where Type I represents the lightest skin tones and Type VI the darkest. Standard pulse oximeters work by measuring how much red and infrared light is absorbed by haemoglobin in capillary blood. Melanin — the pigment that gives skin its colour — absorbs some of this light before it reaches the capillaries.

The clinical problem is not the physics. It is the calibration.

Pulse oximeter calibration tables are built from controlled studies that historically underrepresented individuals with Fitzpatrick skin types IV–VI. When a device’s calibration does not account for high melanin concentration, it may interpret excess light absorption as less oxygenated blood than is actually present — or, more dangerously, may compensate in a direction that produces falsely elevated SpO₂ readings.

A landmark analysis published in the New England Journal of Medicine (Sjoding et al., 2020) found that Black patients were nearly three times as likely as white patients to have occult hypoxemia — SpO₂ measurements that appeared normal on pulse oximetry while arterial blood gas (ABG) testing revealed clinically significant oxygen deficiency.

What the February 2021 FDA Safety Communication Means for Your Readings

The FDA’s February 2021 communication (FDA-2021-N-0010) stated that clinicians should be aware of this limitation when using pulse oximetry for clinical decision-making, particularly in patients with darker skin tones.

What this means in practical terms:

• A SpO₂ reading of 94–95% in a person with Fitzpatrick skin type IV–VI may be masking true saturation of 91–92% or lower
• This bias is present in both finger clip medical-grade devices and consumer wearables — it is a calibration problem, not a device-tier problem
• The bias is most clinically significant when readings are in the 88–96% range — the zone where clinical decisions about supplemental oxygen, hospitalisation, and emergency care are made

What to do if you have darker skin and use a pulse oximeter:

Report any SpO₂ reading below 95% — or any reading that does not match your symptoms — to your provider. Do not assume the device is accurate simply because it displays a number in the normal range. If you have COPD, asthma, or sleep apnea, discuss Fitzpatrick skin tone bias specifically with your pulmonologist, who may recommend confirmatory arterial blood gas testing when clinical decisions are at stake.

References: FDA Safety Communication FDA-2021-N-0010 (February 2021); Sjoding MW et al., NEJM 2020; doi:10.1056/NEJMc2029240.

Common Respiratory Conditions

• COPD — Chronic obstructive disease reducing airflow; monitoring supports exacerbation detection and O₂ therapy titration.
• Asthma — Reversible airway inflammation and bronchoconstriction; SpO₂ monitoring may help assess attack severity.
• Sleep Apnea — Intermittent upper airway obstruction during sleep; nocturnal SpO₂ drops are a key diagnostic indicator.
• COVID-19 / Respiratory Infections — Silent hypoxia — low SpO₂ without perceived breathlessness — has been observed in some COVID-19 cases.[5]
• High-Altitude Exposure — Reduced ambient O₂ may lower SpO₂; altitude sickness risk increases above 2,500 m (8,200 ft).
• Heart Failure — Reduced cardiac output may impair oxygen delivery; respiratory rate and SpO₂ are often monitored together.

COPD: GOLD 2024 Oxygen Targets and Home Monitoring Protocol

Quick Answer: Per GOLD 2024 guidelines, most patients with stable COPD target SpO₂ of 88–92% — deliberately lower than the 95–100% range recommended for healthy adults

This is not an error, and it is not a sign that your doctor is being conservative. It is physiology.

In healthy lungs, the respiratory drive is triggered by rising CO₂ levels. In COPD, years of elevated CO₂ blunt that response. The body compensates by becoming sensitive to falling oxygen instead — a mechanism called the hypoxic respiratory drive. If supplemental oxygen pushes SpO₂ above 92%, this drive can be suppressed, worsening CO₂ retention (hypercapnia) and potentially triggering respiratory failure.

What this means for home monitoring:

• Your COPD-specific target range should be confirmed by your pulmonologist or treating provider — not assumed from general health advice
• A reading of 88–91% may be appropriate for you even when it would represent mild hypoxemia in a healthy person
• A reading that is high for your condition (above 92% during supplemental oxygen use) deserves the same attention as a reading that is low

When to escalate: If your SpO₂ drops more than 4 percentage points below your established baseline, or if you experience increased breathlessness, altered consciousness, or confusion regardless of your SpO₂ reading, contact your provider or seek emergency care.

Per GOLD 2024 Global Strategy for COPD (goldcopd.org/2024-gold-report/). Individual targets must be set by your treating provider.

How often should I check SpO₂ with COPD? Most providers recommend a morning spot-check at rest, taken at the same time each day. More frequent checks are appropriate during exacerbations or when following a written action plan.

→  See the best FDA-cleared pulse oximeters for COPD home monitoring

Asthma: When SpO₂ Monitoring Matters

For people managing asthma

During a flare-up, your lungs can be working much harder than you realize. SpO₂ monitoring gives you an objective data point beyond how you ‘feel’ — so you know when to use your rescue inhaler, when to call your doctor, and when to go to the ER

• Peak expiratory flow (PEF) measurement is the primary recommended home monitoring tool for asthma per GINA guidelines.[12]
• SpO₂ monitoring may be used as an adjunct, particularly in moderate-to-severe asthma or when symptom perception is unreliable.
• Symptom diaries tracking triggers, frequency, and rescue inhaler use remain central to asthma self-management.
• SpO₂ <94% during an asthma episode suggests moderate-to-severe attack and warrants urgent care.

Sleep Apnea: Understanding Nocturnal Oxygen Drops and the Oxygen Desaturation Index (ODI)

Quick Answer: The Oxygen Desaturation Index (ODI) measures how many times per hour SpO₂ drops by 3–4% or more during sleep. An ODI above 5 events per hour is associated with moderate sleep-disordered breathing. Formal sleep apnea diagnosis requires polysomnography (PSG) or a provider-ordered home sleep apnea test (HSAT) — not ODI alone.

During sleep, normal SpO₂ in healthy adults remains 95–100%. Brief, minor fluctuations are expected. What the ODI tracks is sustained, clinically relevant dips — the kind associated with apnea events (breathing pauses) or hypopnea events (partial airway obstruction reducing airflow by 30% or more).

ODI vs. AHI: Why they are not interchangeable:

The Apnea-Hypopnea Index (AHI) is the primary metric used to diagnose and grade sleep apnea severity. It measures breathing events directly. The ODI measures the oxygen consequence of those events — but not the events themselves.

A high ODI suggests oxygen desaturation is occurring during sleep; it does not confirm that the cause is sleep apnea. Positional hypoxemia, obesity hypoventilation, or COPD-related nocturnal desaturation can all produce elevated ODI without the airway obstruction pattern that defines sleep apnea.

What consumer wearables measure:

Most consumer devices that report ODI — including the Withings ScanWatch, Garmin devices, and Oura Ring — use their internal SpO₂ sensor to detect dips during the overnight period.

These readings can identify patterns worth discussing with a provider, but they are not equivalent to PSG or HSAT-measured AHI. Use consumer ODI data as a conversation starter with your sleep physician, not as a diagnosis.

When to seek a formal sleep study:

If your wearable consistently reports an ODI above 5 per hour, if you are experiencing excessive daytime sleepiness, or if a sleep partner reports observed breathing pauses, discuss formal HSAT or PSG referral with your provider.

See also: Sleep and Recovery: Understanding Nocturnal SpO₂ | CPAP vs. BiPAP: Which Is Right for You?

Silent Hypoxia: Clinically Significant Desaturation Without Breathlessness

Quick Answer: Silent hypoxia is clinically significant oxygen desaturation (SpO₂ below 94%) in the absence of subjective breathlessness. The patient does not feel short of breath despite oxygen levels that would normally trigger that sensation.

Silent hypoxia became widely recognised during the COVID-19 pandemic, when clinicians observed a subset of patients presenting with SpO₂ readings in the low-to-mid 80s who reported feeling only mildly unwell.

The phenomenon was formally analysed by Tobin, Laghi, and Jubran in a paper published in the American Journal of Respiratory and Critical Care Medicine (2020), which identified several physiological mechanisms — including preserved lung compliance in early COVID-19 pneumonia and blunted chemoreceptor response — that may explain why the normal breathlessness signal fails to fire.

Why silent hypoxia matters for home monitoring:

The danger of silent hypoxia is delay. A patient who does not feel breathless has no physiological signal prompting them to seek care. By the time breathlessness does appear, desaturation may be severe.

Home pulse oximetry provides an objective measurement that bypasses the subjective breathlessness signal entirely — which is why pulse oximetry became a widely recommended home monitoring tool for COVID-19 patients and remains relevant for high-risk respiratory patients generally.

Who is at elevated risk for silent hypoxia:

• Patients with COVID-19, particularly in the first five to seven days of illness
• Patients with pre-existing blunted hypoxic ventilatory response (common in long-standing COPD)
• Elderly patients, in whom the normal breathlessness response may be attenuated
• Patients on opioid medications, which suppress the respiratory drive

The monitoring implication: If you or a family member is in a high-risk group, do not rely on the absence of breathlessness as reassurance. A pulse oximeter reading is not a substitute for medical evaluation — but a reading below 94% in a symptomatic patient, even without breathlessness, warrants immediate provider contact.

Reference: Tobin MJ, Laghi F, Jubran A. Why COVID-19 Silent Hypoxemia Is Baffling to Physicians. Am J Respir Crit Care Med. 2020;202(3):356–360. doi:10.1164/rccm.202004-1027LE

High Altitude and Exercise-Induced Hypoxemia: What Wearables Show

• In healthy adults, SpO₂ typically remains ≥95% during moderate-to-intense exercise at sea level.[9]
• Exercise-induced hypoxemia (EIH) — defined as a drop in SpO₂ ≥4% during exertion — may be observed in some athletes and individuals with underlying pulmonary disease.
• Consumer wearable accuracy is reduced during high-intensity exercise due to motion artifact; clinical-grade devices or post-exercise spot-checks may be more reliable.
• SpO₂ drops during exercise in individuals with known COPD or interstitial lung disease should be discussed with a provider, as they may affect activity prescriptions.

Pulse oximeter readings can vary based on technique. These steps apply to FDA-cleared finger clip devices. Consumer wearable readings follow different placement protocols specified by each manufacturer.

Before you begin:

• Sit quietly for at least five minutes before measuring — physical activity raises cardiac output and can temporarily affect readings
• Ensure your hands are warm; cold fingers cause vasoconstriction, reducing the signal the sensor can detect
• Remove nail varnish from the finger you will use — dark-pigmented or gel polish interferes with the optical sensor
• Do not measure immediately after a hot shower or bath

Step-by-Step: Correct Pulse Oximeter Technique

1. Choose your finger. The index or middle finger of your non-dominant hand is standard. Avoid the thumb (arterial pulsation pattern differs) and the little finger (thinner tissue bed).
2. Insert your finger fully into the device. The sensor must contact the centre of your fingertip. Partial insertion causes the reading to be inaccurate or unstable.
3. Hold still and breathe normally. Do not hold your breath — this will artificially lower your reading. Breathe at your normal resting rate.
4. Wait for the waveform to stabilise. A good pulse oximeter displays a plethysmographic waveform or a signal-quality indicator. Wait until it shows a consistent, strong signal — typically 30–60 seconds.
5. Record the stable reading. Take the reading once the displayed number has been consistent for at least 10 seconds. A number that fluctuates continuously suggests poor contact or motion interference — reposition and retry.
6. Take three readings and use the highest stable value. Single readings can be affected by transient factors. Three readings over five minutes, discarding outliers, gives a more reliable assessment.

How to Interpret Variability Between Readings

A difference of 1–2% between consecutive readings on the same device is normal and reflects physiological variation, minor movement, and the device’s inherent accuracy tolerance. A difference of 3% or more between readings suggests either technique error, device error, or genuine physiological change.

If readings are consistently lower than your established baseline — not a single low reading, but a pattern over a monitoring session — contact your provider. Do not self-adjust supplemental oxygen based solely on home oximetry readings without provider guidance.

Emergency vs. Urgent vs. Routine: SpO₂ Action Matrix

Read the table with your condition in mind. For most healthy adults, 95–100% is normal. For patients with COPD prescribed a target range of 88–92%, a reading of 90% may fall within their established range — or it may not. If you are unsure whether a reading represents a change from your baseline, contact your provider rather than interpreting in isolation.

Do not wait for breathlessness. Silent hypoxia — clinically significant oxygen desaturation without the sensation of breathlessness — means your body may not alert you to a dangerous drop. A pulse oximeter reading, not your symptoms, is the primary indicator.

Symptoms that require emergency care regardless of SpO₂ reading:

• Confusion, disorientation, or altered consciousness
• Blue or grey discoloration of lips, fingertips, or face (cyanosis)
• Inability to complete a sentence due to breathlessness
• Chest pain or pressure
• Rapid deterioration in SpO₂ over a short period, even if not yet below 90%

Emergency thresholds referenced from: British Thoracic Society Emergency Oxygen Guidelines; WHO Pulse Oximetry Training Manual; GOLD 2024 Global Strategy for COPD.

Setting and Tracking Your Personal Target Range With Your Provider

• SpO₂ readings naturally fluctuate by 1–2% even in healthy individuals due to respiratory cycle variation and sensor motion.[6]
• A single low reading should be repeated after the user is still, warm, and positioned correctly before acting on the result.
• Trending (comparing readings over time under similar conditions) is more clinically meaningful than any single data point.
• Respiratory rate measured by consumer wearables may have higher variability than hospital-grade monitoring equipment.
• Readings taken immediately after exercise, during fever, or with cold extremities may not reflect resting baseline values.

What People Are Saying about Respiratory Monitoring and SpO2

“I check my SpO2 every morning with COPD. This $28 oximeter gives me peace of mind between doctor visits — and I’ve caught two early flare-ups before they got serious.”

— Verified Amazon reviewer, COPD patient, 67

“My mother has asthma and we got her a finger oximeter after her last hospital scare. Now we know the exact number at which to call her doctor vs. wait. It changed how we manage her care.”

— Caregiver reviewer, daughter of 74-year-old asthma patient

“I was skeptical a $30 device could be accurate. After comparing it to the hospital monitor during a check-up, it was within 1%. Sold.”

— Verified reviewer, post-COVID recovery monitoring

References

1. O’Driscoll BR, et al. BTS guideline for oxygen use in adults in healthcare and emergency settings. Thorax. 2017;72(Suppl 1):ii1–ii90.
2. Jubran A. Pulse oximetry. Crit Care. 2015;19:272. doi:10.1186/s13054-015-0984-8
3. Sharma G, Goodwin J. Effect of aging on respiratory system physiology and immunology. Clin Interv Aging. 2006;1(3):253–260.
4. Cretikos MA, et al. Respiratory rate: the neglected vital sign. Med J Aust. 2008;188(11):657–659.
5. Tobin MJ, Laghi F, Jubran A. Why COVID-19 silent hypoxemia is baffling to physicians. Am J Respir Crit Care Med. 2020;202(3):356–360.
6. Nitzan M, Romem A, Koppel R. Pulse oximetry: fundamentals and technology update. Med Devices (Auckl). 2014;7:231–239.
7. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for Prevention, Diagnosis and Management of COPD: 2024 Report. goldcopd.org
8. Luks AM, Swenson ER. Pulse oximetry at high altitude. High Alt Med Biol. 2011;12(2):109–119.
9. Dempsey JA, Wagner PD. Exercise-induced arterial hypoxemia. J Appl Physiol. 1999;87(6):1997–2006.
10. Cote CJ, et al. The effect of nail polish on pulse oximetry. Anesth Analg. 1988;67(7):683–686.
11. U.S. Food and Drug Administration. Pulse Oximeter Accuracy and Limitations: FDA Safety Communication. February 2021. fda.gov
12. Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention. 2023 Update. ginasthma.org
13. Lévy P, et al. Obstructive sleep apnoea syndrome. Nat Rev Dis Primers. 2015;1:15015.
14. World Health Organization. Clinical Management of COVID-19: Living Guideline. who.int

Explore Respiratory Monitoring Topics

Know Someone Who Could Use This Guide?

If you’re caring for a family member with COPD, asthma, or sleep apnea — or if you’re a patient yourself — this free guide explains exactly what oxygen readings mean and when to act.

Pre-written caption for Facebook / health groups:

“Free guide for anyone managing COPD or asthma at home. Explains exactly what SpO₂ readings mean, when to call your doctor vs. go to the ER, and which pulse oximeter is worth buying. No sign-up needed. → ”